| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.08 | 0.05 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |